Search clinical trials for: AZD0530 (saracatinib)
Total 74 results
-
Yale UniversityAlzheimer's Therapeutic Research InstituteCompletedAlzheimer's DiseaseUnited States, Canada
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Stage IIB Melanoma | Stage IIC Melanoma | Stage IIA MelanomaUnited States
-
Yale UniversityCompleted
-
National Cancer Institute (NCI)TerminatedInvasive Thymoma and Thymic Carcinoma | Recurrent Thymoma and Thymic Carcinoma | Stage III Thymoma | Stage IVA Thymoma | Stage IVB ThymomaUnited States
-
Baylor College of MedicineUniversity of South Florida; National Institutes of Health (NIH); Brigham and... and other collaboratorsTerminatedPulmonary LymphangioleiomyomatosisUnited States
-
Stephen M. StrittmatterNational Institute of Neurological Disorders and Stroke (NINDS)CompletedAlzheimer's DiseaseUnited States
-
National Cancer Institute (NCI)CompletedUterine Carcinosarcoma | Endometrial Stromal Sarcoma | Recurrent Adult Soft Tissue Sarcoma | Recurrent Uterine Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage III Uterine Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Stage IV Uterine Sarcoma | Dermatofibrosarcoma Protuberans | Adult Rhabdomyosarcoma and other conditionsCanada, United States
-
National Cancer Institute (NCI)CompletedTongue Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma of the Oropharynx and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedAdenocarcinoma of the Gastroesophageal Junction | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Stage III Gastric Cancer | Adenocarcinoma of the Stomach | Stage IV Esophageal Cancer | Stage III Esophageal CancerCanada, United States
-
National Cancer Institute (NCI)CompletedLung Metastases | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Malignant Pleural EffusionUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerCanada
-
National Cancer Institute (NCI)TerminatedStage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Adenocarcinoma of the Rectum | Adenocarcinoma of the ColonUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate CancerUnited States
-
AstraZenecaCompleted
-
National Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast CancerUnited States
-
AstraZenecaCompleted
-
National Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage IV Prostate CancerUnited States
-
Tony EissaUniversity of Texas; University of CincinnatiCompletedPulmonary LymphangioleiomyomatosisUnited States
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol DrinkingUnited States
-
Amsterdam UMC, location VUmcAstraZeneca; Brigham and Women's Hospital; University of Oxford; Klinikum Garmisch-Patenkirchen and other collaboratorsRecruitingFibrodysplasia Ossificans ProgressivaGermany, Netherlands, United Kingdom
-
AstraZenecaCompleted
-
NCIC Clinical Trials GroupAstraZenecaCompleted
-
AstraZenecaCompleted
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
AstraZenecaCompleted
-
Joyce Marie SlingerlandStanford UniversityCompleted
-
AstraZenecaCompletedOvarian Neoplasms | Ovarian CancerBulgaria, Peru, Russian Federation, Romania, Norway, Canada, Denmark, Netherlands, Portugal, United Kingdom, France, Spain
-
AstraZenecaCompletedBreast Cancer | Bone Neoplasms | Prostate CancerUnited States, United Kingdom, Sweden, Norway, Canada, Portugal, Denmark, Spain
-
AstraZenecaWithdrawnCancer | Non Small Cell Lung Cancer | Epithelial Ovarian CancerJapan
-
National Cancer Institute (NCI)CompletedAdenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage IV Pancreatic CancerUnited States, Singapore, Australia
-
AstraZenecaQuotient SciencesCompleted
-
AstraZenecaAstraZeneca K.K.RecruitingDyslipidemiaDenmark, Hungary, Spain, United States, Japan, Czechia, Slovakia, Canada
-
AstraZenecaCompletedPharmacokinetics | Healthy Participants | Tolerability | SafetyUnited States
-
National Jewish HealthYale University; Icahn School of Medicine at Mount Sinai; AstraZeneca; Baylor University and other collaboratorsRecruitingIdiopathic Pulmonary Fibrosis (IPF)United States
-
AstraZenecaCompleted
-
AstraZenecaParexelRecruitingDilated CardiomyopathyUnited States
-
AstraZenecaRecruitingMultiple MyelomaUnited States, Spain, Australia, Canada, Germany, China, Japan
-
AstraZenecaRecruitingSteatohepatitisUnited States, Puerto Rico
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
Merck Sharp & Dohme LLCTerminatedLiver Diseases | Digestive System Diseases | RNA Virus Infections | Virus Diseases | Flaviviridae Infections | Hepatitis | Hepatitis, Viral, Human | Hepatitis C
-
King's College LondonKing's College Hospital NHS Trust; AstraZenecaUnknownParkinson Disease PsychosisUnited Kingdom
-
AstraZenecaCompletedNon-alcoholic Fatty Liver Disease | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | NASH | Fatty Liver, NonalcoholicUnited States
-
AstraZenecaParexelCompletedNon-alcoholic SteatohepatitisUnited Kingdom
-
AstraZenecaCompletedAsthmaUnited States, Germany, United Kingdom
-
AstraZenecaRecruitingNon-alcoholic Steatohepatitis (NASH)Austria, Germany, Sweden
-
AstraZenecaActive, not recruiting